http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2533254-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_511f6422bd60c264b64e83866b0736ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d19b1c2976e37f1151e3fba5e6a37eae |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2012-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2e1339b57759f4b844763d6992a813d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9841abaf40ebeaf047831f3943603abc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6848c39f521ff713e4874b758c3fad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03003faf4f0a976db474fa3ed1e9f01c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76930a4c3997b610d25822a1d1641a05 |
| publicationDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2533254-C2 |
| titleOfInvention | Method of treating neurological complications of varicella in children |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to neurology, and concerns treating neurological complications of varicella in children. That is ensured by administering acyclovir, interferon and intravenous immunoglobulins. Acyclovir is administered in a dose of 10-15 mg/kg 3 times a day in a combination with viferon in rectal suppositories of 500,000-1,000,000 International Units 2 times a day for 10-14 days. Intravenous immunoglobulin G is administered in a dose of 0.4 mg/kg once a day for 3 days. If observing a severe condition in a combination with multiple CNS involvements, the antiviral therapy is added with administering Metypred 500-1000 mg once a day intravenously drop-by-drop and Elcar 50-70 mg/kg once a day for 5-7 days, then 50-70 mg/kg twice a day orally. n EFFECT: complex of the antiviral and specific causal treatment provides the higher clinical effectiveness and reducing the length of treatment of the neurological complications of varicella in children. n 2 cl, 4 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786753-C1 |
| priorityDate | 2012-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.